pipeline
Overview
Silence is a clear leader in the development of clinical-stage RNAi therapeutics, having developed a broad pipeline of internal and partnered product candidates.
Silence's technology serves as an important foundation in at least half of the siRNA programs in clinical development worldwide, demonstrating the significant impact that the company’s RNAi platform has within the sector. Silence’s impressive pipeline of products not only validates the strength of the company’s technology but also the depth of knowledge that has guided the development path.
